Kevin J. Appelbaum

Insider Reports History

Entity
Individual
Location
4160 Dublin Blvd., Suite 200, Dublin, CA
Signature
/s/ Mark Heinen, Attorney-in-Fact for Kevin J. Appelbaum
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin J. Appelbaum:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Better Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner Common Stock 2.41M $409K $0.17 Mar 31, 2022 By Trust
Better Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner Common Stock 6.25K $1.06K $0.17 Mar 31, 2022 Direct
Better Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner Stock Option (Right to Buy) 235K Apr 1, 2022 Direct

Insider Reports Filed by Kevin J. Appelbaum

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BTTX Better Therapeutics, Inc. Mar 31, 2022 2 $4.92K 4 Apr 4, 2022 Chief Executive Officer, Director, 10%+ Owner
BTTX Better Therapeutics, Inc. Dec 20, 2021 1 $4.6K 4 Dec 22, 2021 Chief Executive Officer, Director, 10%+ Owner
BTTX Better Therapeutics, Inc. Dec 15, 2021 1 $3.53K 4 Dec 17, 2021 Chief Executive Officer, Director, 10%+ Owner
BTTX Better Therapeutics, Inc. Dec 10, 2021 1 $5.98K 4 Dec 14, 2021 Chief Executive Officer, Director, 10%+ Owner
BTTX Better Therapeutics, Inc. Dec 2, 2021 2 $6.63K 4 Dec 6, 2021 Chief Executive Officer, Director, 10%+ Owner
BTTX Better Therapeutics, Inc. Oct 28, 2021 0 $0 3 Nov 1, 2021 Chief Executive Officer, Director, 10%+ Owner